This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
On World Arthritis Day ‘Don’t Delay, Connect ... On World Arthritis Day ‘Don’t Delay, Connect Today’ Campaign ... (15 Oct 2018)
3D mammography detected 34% more breast ... “With breast tomosynthesis, 34 per cent more cancer tumours were ... (15 Oct 2018)
Breastfeeding protects infants from ...  A new study from the University of Helsinki shows that babies ... (15 Oct 2018)
Reduced risk of severe stroke for ... Physical activity not only reduces the risk of stroke. ... (15 Oct 2018)
Link between Gut Flora and Multiple ...  In multiple sclerosis, a defective response of the body’s own ... (15 Oct 2018)
Wednesday, 03 October 2018 19:49

Smokers with peripheral artery disease need more help to kick the habit Featured

Rate this item
(0 votes)

While many people with peripheral artery disease (PAD) smoke, few receive proven smoking cessation strategies from their doctor, according to new research in the Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.


Worldwide, 202 million adults are affected by peripheral artery disease which is a narrowing of the arteries serving the legs, stomach, arms and head. Peripheral artery disease most commonly affects arteries in the legs.

“Smoking is the single most important risk factor for development and progression of peripheral artery disease,” said study author Krishna K. Patel, M.D., M.Sc., a cardiology fellow at the University of Missouri-Kansas City, Saint Luke’s Mid America Heart Institute. “More importantly, it is modifiable. Smoking cessation is the cornerstone for managing patients with this disease.”

Researchers studied the smoking behaviors of more than 1,200 patients who had gone to specialty vascular clinics to be treated for peripheral artery disease. Patients were experiencing new or worsening leg pain or cramping when exercising because muscles in the legs or other limbs were not getting enough blood flow (claudication).
Researchers found:
37 percent of peripheral artery disease patients were active smokers.
16 percent received a referral to a smoking cessation counseling program and 11 percent received drug treatment or nicotine replacement therapy.
36 percent of peripheral artery disease smokers who quit relapsed within a year.
72 percent of active peripheral artery disease smokers continued smoking after a year.
Patients’ chances of quitting were highest within the first three months after visiting their specialty providers.
“Many patients continue smoking or relapse after they attempt to quit. Doctors taking care of these patients need to be aware of this and provide consistent, ongoing cessation support to their smoking patients at every opportunity they get with them,” Patel said.
Patients should not be afraid to reach out to their doctors, friends and family and other cessation support services if they need additional help to quit or to prevent relapses.”

The study excluded patients without symptoms related to peripheral artery disease or those whose disease was not severe enough to require a specialist or who may have received care at their primary care physicians’ offices.

“The next step is to identify the barriers in providing adequate smoking cessation support for PAD patients in order to identify what works and what could be improved upon,” Patel said.



Source: American Heart Association
Full bibliographic information

Underutilization of Evidence-Based Smoking Cessation Support Strategies Despite High Smoking Addiction Burden in Peripheral Artery Disease Specialty Care: Insights from the International PORTRAIT Registry

Read 89 times Last modified on Tuesday, 02 October 2018 12:22

TheSynapse Videos

0
0
0
0
0
0

Latest news

Highlights

  • Les Laboratoires Servier - Job Vacancy
    Written on June 29, 2018 Read more...
  • Interactive Discussion on Valsartan

     

     

    The Malta Medicines Authority in collaboration with the Superintendence
    of Public Health and the Department of Pharmacy University of Malta
    would like to cordially invite you to an interactive scientific discussion:

     

     


    THE VALSARTAN SAGA


    SCIENCE | MYTHS | REALITIES

     


    led by Professor Anthony Serracino Inglott

     


    Date: Wednesday 25 July 2018

     


    Time: 20:00
    Venue: Conference Room, Life Sciences Park, San Ġwann

     


    Refreshments will be served


    RSVP: info.medicinesauthority@gov.mt | 23439202

    Written on July 21, 2018

Join

Connect with other Medical Professionals on fb in a closed facebook group

captcha  

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…